Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent for Glaxosmithkline drug ANORO ELLIPTA a…
New patent for Glaxosmithkline drug ANORO ELLIPTA Read Post »
Annual Drug Patent Expirations for LILETTA Liletta is a drug marketed by Medicines360 and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for Medicines360 drug LILETTA appeared first on Dru…
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent for Glaxosmithkline drug TRELEGY ELL…
New patent for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
This chart shows the pharmaceutical companies with the most patents in Iceland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Iceland? Read Post »
Annual Drug Patent Expirations for QDOLO Qdolo is a drug marketed by Athena and is included in one NDA. The generic ingredient in QDOLO is tramadol hydrochloride. Additional details are…
The post New patent for Athena drug QDOLO appeared first on DrugP…
ZYVOX (linezolid) Pfizer Patent: 6,514,529 Expiration: Sep 15, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Patent E…
Drug Patent Expirations for the Week of September 12, 2021 Read Post »
Annual Drug Patent Expirations for ROZLYTREK Rozlytrek is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are twelve patents…
The post New patent for Genentech Inc drug ROZLYTREK appeared first on D…
Annual Drug Patent Expirations for NATESTO Natesto is a drug marketed by Acerus and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Acerus drug NATESTO appeared first on DrugPatentWa…
Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Zogenix Inc drug FINTEPLA appeared first on DrugPate…
Annual Drug Patent Expirations for UPNEEQ Upneeq is a drug marketed by Rvl Pharms and is included in one NDA. There are seven patents protecting this drug. This drug has…
The post New patent for Rvl Pharms drug UPNEEQ appeared first on DrugPatentWatch …
Get new actionable insights and updates from BiotechBlog
